130 related articles for article (PubMed ID: 38818946)
21. Molecular Mobility and Crystal Growth in Amorphous Binary Drug Delivery Systems: Effects of Low-Concentration Poly(Ethylene Oxide).
Shi Q; Cheng J; Li F; Xu J; Zhang C
AAPS PharmSciTech; 2020 Nov; 21(8):317. PubMed ID: 33175339
[TBL] [Abstract][Full Text] [Related]
22. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.
Zhang J; Shi Q; Guo M; Liu Z; Cai T
Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128
[TBL] [Abstract][Full Text] [Related]
23. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
Yamashita H; Sun CC
Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
[TBL] [Abstract][Full Text] [Related]
24. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
25. Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.
Sun Y; Zhu L; Wu T; Cai T; Gunn EM; Yu L
AAPS J; 2012 Sep; 14(3):380-8. PubMed ID: 22434258
[TBL] [Abstract][Full Text] [Related]
26. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
27. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
[TBL] [Abstract][Full Text] [Related]
28. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
Phadke C; Sharma J; Sharma K; Bansal AK
Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
[TBL] [Abstract][Full Text] [Related]
30. Influence of Drug-Polymer Interactions on Dissolution of Thermodynamically Highly Unstable Cocrystal.
Jasani MS; Kale DP; Singh IP; Bansal AK
Mol Pharm; 2019 Jan; 16(1):151-164. PubMed ID: 30482019
[TBL] [Abstract][Full Text] [Related]
31. Stable carbamazepine colloidal systems using the cosolvent technique.
Douroumis D; Fahr A
Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
[TBL] [Abstract][Full Text] [Related]
32. Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.
Shi Q; Zhang C; Su Y; Zhang J; Zhou D; Cai T
Mol Pharm; 2017 Jul; 14(7):2262-2272. PubMed ID: 28548840
[TBL] [Abstract][Full Text] [Related]
33. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
34. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
[TBL] [Abstract][Full Text] [Related]
35. Low-concentration polymers inhibit and accelerate crystal growth in organic glasses in correlation with segmental mobility.
Powell CT; Cai T; Hasebe M; Gunn EM; Gao P; Zhang G; Gong Y; Yu L
J Phys Chem B; 2013 Sep; 117(35):10334-41. PubMed ID: 23909486
[TBL] [Abstract][Full Text] [Related]
36. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
[TBL] [Abstract][Full Text] [Related]
37. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
38. Role of molecular interaction in stability of celecoxib-PVP amorphous systems.
Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
Mol Pharm; 2005; 2(5):384-91. PubMed ID: 16196491
[TBL] [Abstract][Full Text] [Related]
39. Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.
Shi K; Li M
Pharm Res; 2023 Aug; 40(8):2051-2069. PubMed ID: 37188904
[TBL] [Abstract][Full Text] [Related]
40. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
